Emphasizing the Personal Versus the Social in Educational Interventions For Decreasing Vaccine Hesitancy

November 11, 2021 updated by: National Research University Higher School of Economics

Me or We? Emphasizing the Personal Versus the Social in Educational Interventions For Decreasing Vaccine Hesitancy

This experimental study aims to investigate the effect of different types of educational interventions on overcoming Coronavirus disease 2019 (COVID-19) vaccine hesitancy among the Higher School of Economics (HSE) bachelor students in Russia.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

The researchers aim to investigate the effectiveness of three types of educational interventions on overcoming COVID-19 vaccine hesitancy among the HSE bachelor students. The study design implies the comparison of three types of educational interventions which differ in the message that they deliver to the participants: the personal, the social, and a combination of the two. The effects of these interventions will be compared to the control group with no intervention.

Participants in these three experimental groups will receive a link to an educational video about the benefits and costs of vaccination against COVID-19. The videos for the three groups will contain information about vaccination, but each of them will have a different focus.

The participants will be hired on a voluntary basis. All the participants will sign the informed consent form, and the measures will be taken to ensure that their personal data will be protected.

Study Type

Interventional

Enrollment (Anticipated)

4000

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Anastasia Kapuza
  • Phone Number: 22094 + 7 (495) 772 9590
  • Email: akapuza@hse.ru

Study Contact Backup

  • Name: Iuliia Gerasimova
  • Phone Number: 22094 + 7 (495) 772 9590
  • Email: ygerasimova@hse.ru

Study Locations

  • Russian Federation
      • Moscow, Russian Federation
        • Higher School of Economics
        • Contact:
          • Anastasia Kapuza
          • Phone Number: 22094 + 7 (495) 772 9590
          • Email: akapuza@hse.ru
        • Contact:
          • Aynur Kulieva
          • Phone Number: 22094 + 7 (495) 772 9590
          • Email: akulieva@hse.ru

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 25 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • HSE bachelor students from 18 to 25 years old, who agreed to participate in the study.

Exclusion Criteria:

  • Students who have got vaccinated already.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control Group
Participants do not undergo any intervention. Pre-and post data collection only.
Experimental: Personal
Participants are exposed to the message about the personal benefits (and costs) of vaccination which refers to their own safety, their freedoms, their worries about the well-being of their significant others.
Behavioral: "Personal" intervention
Participants will receive a link with an invitation to watch a 10-minute educational video about the personal benefits and costs of vaccination against COVID-19. They will also go through pre-and post-test data collection.
Experimental: Social
Participants are exposed to the message about the social benefits (and costs) of vaccination which refers to public safety, the well-being of others in their community, the vulnerable groups, etc.
Behavioral: "Social" intervention
Participants will receive a link with an invitation to watch a 10-minute educational video about the social benefits and costs of vaccination against COVID-19. They will also go through pre-and post-test data collection.
Experimental: Personal + Social
Participants are exposed to the message about both personal and social benefits (and costs) of vaccination. The message alludes to personal safety as well as public safety and the strain on the healthcare system associated with the uncontrollable spread of the virus.
Behavioral: "Personal" + "Social" intervention
Participants will receive a link with an invitation to watch a 10-minute educational video about both personal and social benefits and costs of vaccination against COVID-19. They will also go through pre-and post-test data collection.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Real vaccination status
Time Frame: 1-3 months
Participants report whether they have got vaccinated against COVID-19.
1-3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knowledge, attitudes, and self-reported behaviors
Time Frame: 1-3 months
Participants will be given a questionnaire to test their knowledge, attitudes towards vaccination, and self-reported behaviors surrounding vaccination and safety protocols. The questionnaire will be designed by the researchers.
1-3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

National Research University Higher School of Economics

Collaborators

Stanford University

Investigators

  • Study Chair: Prashant Loyalka, PhD, Stanford University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

November 1, 2021

Primary Completion (Anticipated)

January 1, 2022

Study Completion (Anticipated)

January 1, 2022

Study Registration Dates

First Submitted

November 2, 2021

First Submitted That Met QC Criteria

November 11, 2021

First Posted (Actual)

November 15, 2021

Study Record Updates

Last Update Posted (Actual)

November 15, 2021

Last Update Submitted That Met QC Criteria

November 11, 2021

Last Verified

November 1, 2021

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • hsestudy2021

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

The deidentified individual participant data (IPD) collected in the course of the experiment will be made available. The Study Protocol, Statistical Analysis Plan, and Informed Consent Form will also be available.

All data will be available on request after 6 months following article publication.

IPD Sharing Time Frame

6 months following article publication

IPD Sharing Access Criteria

The IPD will be shared upon request with a sound description of the intended study.

IPD Sharing Supporting Information Type

  • Study Protocol
  • Analytic Code

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Communication

Clinical Trials on "Personal" intervention

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malaysia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe